NCT05776732

Brief Summary

Malignant tumor patients are at high risk of medical adhesive-related skin injury(MARSI).MARSI can cause local skin ulceration, increase the difficulty of fixation and maintenance frequency, even cause unplanned extubation, and increase the pain and economic burden of the patient's re-installation.Malignant tumor patients with long-term PICC are prone to MARSI.CaviionTM can form a protective film on the skin.Applying CaviionTM before using the adhesive can effectively protect the skin and reduce the occurrence of rash.In China, CaviionTM is mostly used in infants and young children, but adults lack corresponding report and application data.Therefore, it is necessary to carry out corresponding randomized controlled study on adult patients, especially malignant tumors

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
165

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 7, 2022

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 15, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 20, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

March 20, 2023

Status Verified

February 1, 2023

Enrollment Period

1.6 years

First QC Date

February 15, 2023

Last Update Submit

March 8, 2023

Conditions

Keywords

PICCmedical adhesive-related skin injury

Outcome Measures

Primary Outcomes (1)

  • Incidence of medical viscose-related skin injury

    Including mechanical injury (exfoliation, skin tear, tension injury), dermatitis (contact dermatitis and allergic dermatitis), others (immersion and folliculitis)

    1year

Study Arms (2)

CaviionTM group

EXPERIMENTAL

The first nursing is performed within 48 hours after PICC intubation, and each nursing is not more than 7 days thereafter. The nursing contents include skin disinfection, dressing replacement, flushing and locking venous catheters, needleless connector change. After the disinfectant was dried, the experimental group applied CaviionTM on the skin around the catheter and waited for 30 seconds before sticking the dressing.

Other: 3M CaviionTM

Routine care group

NO INTERVENTION

The first nursing is performed within 48 hours after PICC intubation, and each nursing is not more than 7 days thereafter. The nursing contents include skin disinfection, dressing replacement, flushing and locking venous catheters, needleless connector change.

Interventions

3M CaviionTM is mainly composed of acrylate trimer, non-toxic, alcohol-free, and compatible with chlorhexidine gluconate and povidone iodine.

CaviionTM group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For malignant tumor patients newly implanted with PICC,indwelling catheter for more than 1 month,Conduct catheter maintenance in my hospital during observation

You may not qualify if:

  • People with skin disease around PICC tube,Psychopath

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

石芸

Hangzhou, ZhwJiang, 310009, China

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: 3M CaviionTM
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2023

First Posted

March 20, 2023

Study Start

March 7, 2022

Primary Completion

October 30, 2023

Study Completion

December 30, 2023

Last Updated

March 20, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations